ROGELIO CRUZ: Open Payments
NPI 1205827763 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,797 in 57 payments from 11 companies in 2025. Trend: 2023 $2,204 · 2024 $2,081 · 2025 $4,797
Food & beverage: $3,450Travel & lodging: $1,347
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 12 | $2,351 |
| E.R. Squibb & Sons, L.L.C. | 10 | $406 |
| BIOTRONIK INC. | 6 | $366 |
| AstraZeneca Pharmaceuticals LP | 6 | $361 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $274 |
| Medtronic, Inc. | 4 | $268 |
| Abbott Laboratories | 2 | $229 |
| Novo Nordisk Inc | 4 | $163 |
| Amgen Inc. | 6 | $162 |
| Inspire Medical Systems, Inc. | 1 | $137 |
Products named: Barostim Neo System, LifeVest, CAMZYOS, SYNCHROMEDII, AVEIR, FARXIGA, REPATHA, LOKELMA.
Industry payments across TX — which companies pay providers there.
